Christian Hassager: Clinical Trials

5 trials sponsored by Christian Hassager, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1
Phase 31Recruiting 1

Follow Christian Hassager: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest
esketamine hydrochloride, propofol - Out-of-hospital Cardiac Arrest (OHCA)
Phase 2RecruitingChristian Hassager2822024-12-122024-12-20
The Danish Out-of-Hospital Cardiac Arrest Study
Dexamethasone, Backrest elevation, Early wakeup call - Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome
Phase 3RecruitingChristian Hassager10002023-06-162025-01-24
Evaluation of ReDS Pro System V2.7 and ReDS ICU in Patients With Heart Failure
Remote Dielectric Sensing (ReDS) - Heart Failure
UnknownChristian Hassager252022-06-132022-06-14
Steroid Treatment After Resuscitated Out-of-Hospital Cardiac Arrest
Methylprednisolone, Isotonic saline - Out-Of-Hospital Cardiac Arrest, Cardiac Arrest
Phase 2CompletedChristian Hassager1582020-10-102023-03-29
IL-6 Inhibition for Modulating Inflammation After Cardiac Arrest
Tocilizumab 20 Mg/mL Intravenous Solution, isotonic saline - Heart Arrest, Out-Of-Hospital Cardiac Arrest
Phase 2CompletedChristian Hassager802019-03-042020-08-21

Conditions studied

Out-of-Hospital Cardiac Arrest (4)  ·  Inflammation (3)  ·  Systemic Inflammatory Response Syndrome (3)  ·  Heart Arrest (2)  ·  Post-Cardiac Arrest Syndrome (2)  ·  Delirium (1)  ·  Heart Failure (1)  ·  Trauma, Nervous System (1)

Interventions

Sodium Chloride (2)  ·  Dexamethasone (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Olanzapine (1)  ·  Propofol (1)  ·  tocilizumab (1)

Countries

Denmark (5)

Top investigators

Jesper Kjaergaard, MD PhD DMSc (1)

Results publications

PMID 33081828, PMID 33745292, PMID 36414975, PMID 36572373, PMID 37943300, PMID 38254130, PMID 39094677, PMID 39510308, PMID 41807121, PMID 42251862, PMID 42328133, PMID 42338242, PMID 42338278, PMID 42349503